{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:01:37Z","timestamp":1775728897588,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100024159","name":"Dr. Reddy\u2019s Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024159","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12325-026-03500-y","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:48:42Z","timestamp":1771224522000},"page":"1622-1638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Practice-Based Consensus Amongst Indian Neurologists: Adopting Remote Electrical Neuromodulation for Effective Management of Migraine"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-5438","authenticated-orcid":false,"given":"Debashish","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-6213","authenticated-orcid":false,"given":"Jaydip Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravar","family":"Passi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajasekar","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-7909","authenticated-orcid":false,"given":"T. K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-7087","authenticated-orcid":false,"given":"Mayank Ravindra","family":"Dhore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-3272","authenticated-orcid":false,"given":"Sujeet Narayan","family":"Charugulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0992-1028","authenticated-orcid":false,"given":"Bhavesh P.","family":"Kotak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-6521","authenticated-orcid":false,"given":"Sukhpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"3500_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01700-3","volume":"25","author":"M Leonardi","year":"2024","unstructured":"Leonardi M, Martelletti P, Burstein R, et al. The World Health Organization intersectoral global action plan on epilepsy and other neurological disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain. 2024;25:4. https:\/\/doi.org\/10.1186\/s10194-023-01700-3.","journal-title":"J Headache Pain"},{"key":"3500_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01666-2","volume":"24","author":"P Martelletti","year":"2023","unstructured":"Martelletti P, Leonardi M, Ashina M, et al. Rethinking headache as a global public health case model for reaching the SDG 3 health by 2030. J Headache Pain. 2023;24:140. https:\/\/doi.org\/10.1186\/s10194-023-01666-2.","journal-title":"J Headache Pain"},{"key":"3500_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01735-0","volume":"25","author":"M Waliszewska-Pros\u00f3\u0142","year":"2024","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Montisano DA, Antolak M, et al. The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. J Headache Pain. 2024;25:27. https:\/\/doi.org\/10.1186\/s10194-024-01735-0.","journal-title":"J Headache Pain"},{"key":"3500_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi A, Leonardi M, Arruda M, et al. Hallmarks of primary headache: part 1 - migraine. J Headache Pain. 2024;25:189. https:\/\/doi.org\/10.1186\/s10194-024-01889-x.","journal-title":"J Headache Pain"},{"key":"3500_CR5","unstructured":"Migraine: The American Headache Society update on integrating new migraine treatments into clinical practice. 2021. Philadelphia: Lippincott Nursing Center; 2023. https:\/\/www.nursingcenter.com\/getattachment\/Clinical-Resources\/Guideline-Summaries\/Migraine\/GuidelineSummary_Migraine_May-2023.pdf.aspx. Accessed 8 Jan 2025."},{"key":"3500_CR6","doi-asserted-by":"publisher","first-page":"033310242412673","DOI":"10.1177\/03331024241267309","volume":"44","author":"MFP Peres","year":"2024","unstructured":"Peres MFP, Sacco S, Pozo-Rosich P, et al. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: a call to action. Cephalalgia. 2024;44:03331024241267309. https:\/\/doi.org\/10.1177\/03331024241267309.","journal-title":"Cephalalgia"},{"key":"3500_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022;23:34. https:\/\/doi.org\/10.1186\/s10194-022-01402-2.","journal-title":"J Headache Pain"},{"key":"3500_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease study 2021. Lancet Neurol. 2024;23:344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"key":"3500_CR9","doi-asserted-by":"publisher","first-page":"e1129","DOI":"10.1016\/S2214-109X(21)00164-9","volume":"9","author":"G Singh","year":"2021","unstructured":"Singh G, Sharma M, Kumar GA, et al. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990\u20132019. Lancet Glob Health. 2021;9:e1129\u201344. https:\/\/doi.org\/10.1016\/S2214-109X(21)00164-9.","journal-title":"Lancet Glob Health"},{"key":"3500_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1030940","volume":"13","author":"A Sudershan","year":"2023","unstructured":"Sudershan A, Pushap AC, Younis M, et al. Neuroepidemiology study of headache in the region of Jammu of north Indian population: a cross-sectional study. Front Neurol. 2023;13:1030940. https:\/\/doi.org\/10.3389\/fneur.2022.1030940.","journal-title":"Front Neurol"},{"key":"3500_CR11","doi-asserted-by":"publisher","first-page":"033310242412526","DOI":"10.1177\/03331024241252666","volume":"44","author":"F Puledda","year":"2024","unstructured":"Puledda F, Sacco S, Diener HC, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia. 2024;44:03331024241252666. https:\/\/doi.org\/10.1177\/03331024241252666.","journal-title":"Cephalalgia"},{"key":"3500_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61:1021\u201339. https:\/\/doi.org\/10.1111\/head.14153.","journal-title":"Headache"},{"key":"3500_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0333102420905307","volume":"40","author":"RB Lipton","year":"2020","unstructured":"Lipton RB, Marcus SC, Shewale AR, Dodick DW, Viswanathan HN, Doshi JA. Acute treatment patterns in patients with migraine newly initiating a triptan. Cephalalgia. 2020;40:437\u201347. https:\/\/doi.org\/10.1177\/0333102420905307.","journal-title":"Cephalalgia"},{"key":"3500_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30854-y","volume":"13","author":"F Rimmele","year":"2023","unstructured":"Rimmele F, M\u00fcller B, Becker-Hingst N, et al. Medication adherence in patients with cluster headache and migraine: an online survey. Sci Rep. 2023;13:4546. https:\/\/doi.org\/10.1038\/s41598-023-30854-y.","journal-title":"Sci Rep"},{"key":"3500_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01814-2","volume":"25","author":"D Chowdhury","year":"2024","unstructured":"Chowdhury D, Krishnan A, Duggal A, Amarchand R, Hus\u00f8y A, Steiner TJ. Headache prevalence and demographic associations in the Delhi and National Capital Region of India: estimates from a cross-sectional nationwide population-based study. J Headache Pain. 2024;25:108. https:\/\/doi.org\/10.1186\/s10194-024-01814-2.","journal-title":"J Headache Pain"},{"key":"3500_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1033-9","volume":"20","author":"AM Rapoport","year":"2019","unstructured":"Rapoport AM, Bonner JH, Lin T, et al. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications. J Headache Pain. 2019;20:83. https:\/\/doi.org\/10.1186\/s10194-019-1033-9.","journal-title":"J Headache Pain"},{"key":"3500_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10072-021-05664-7","volume":"43","author":"O Clark","year":"2022","unstructured":"Clark O, Mahjoub A, Osman N, Surmava AM, Jan S, Lagman-Bartolome AM. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Neurol Sci. 2022;43:153\u201365. https:\/\/doi.org\/10.1007\/s10072-021-05664-7.","journal-title":"Neurol Sci"},{"key":"3500_CR18","unstructured":"Theranica. Theranica enters into agreement with Dr. Reddy\u2019s for commercializing Nerivio\u00ae in India [press release]. Netanya, Israel: Theranica Bio-Electronics Ltd; 2023 Jan 10. https:\/\/www.nerivio.com\/news-press\/theranica-enters-into-agreement-with-dr-reddys-for-commercializing-nerivio-r-in-india. Accessed 7 Jan 2025."},{"key":"3500_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/head.14469","volume":"63","author":"SJ Tepper","year":"2023","unstructured":"Tepper SJ, Rabany L, Cowan RP, et al. Remote electrical neuromodulation for migraine prevention: a double-blind, randomized, placebo-controlled clinical trial. Headache. 2023;63:377\u201389. https:\/\/doi.org\/10.1111\/head.14469.","journal-title":"Headache"},{"key":"3500_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2217\/pmt-2022-0053","volume":"12","author":"B Grosberg","year":"2022","unstructured":"Grosberg B, Rabany L, Vizel M, et al. Effectiveness comparison of remote electrical neuromodulation and standard-care medications for acute treatment of chronic migraine: a post-hoc analysis. Pain Manag. 2022;12:837\u201344. https:\/\/doi.org\/10.2217\/pmt-2022-0053.","journal-title":"Pain Manag"},{"key":"3500_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/pm\/pnab197","volume":"23","author":"AD Hershey","year":"2021","unstructured":"Hershey AD, Irwin SL, Rabany L, et al. Comparison of remote electrical neuromodulation and standard-care medications for acute treatment of migraine in adolescents: a post-hoc analysis. Pain Med. 2021;23:815\u201320. https:\/\/doi.org\/10.1093\/pm\/pnab197.","journal-title":"Pain Med"},{"key":"3500_CR22","unstructured":"INS Guidelines. 2024. International Neuromodulation Society. https:\/\/www.neuromodulation.com\/ins-guidelines. Accessed 8 Jan 2025"},{"key":"3500_CR23","unstructured":"Central Drugs Standard Control Organisation, 2023. File no. HQ\/MD\/2023\/000012. Dated 30 Nov 2023. Accessed 14 Aug 2025."},{"key":"3500_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12883-025-04291-5","volume":"25","author":"AZ Alnajjar","year":"2025","unstructured":"Alnajjar AZ, Mustafa MM, Abdelsalam OK, et al. Efficacy and safety of remote electrical neuromodulation in migraine: a comprehensive systematic review and meta-analysis. BMC Neurol. 2025;25:291. https:\/\/doi.org\/10.1186\/s12883-025-04291-5.","journal-title":"BMC Neurol"},{"key":"3500_CR25","unstructured":"Migraine Neuromodulation Devices: Nerivio vs. GammaCore vs. Cefaly vs. Spring TMS. Virtual Headache Specialist. 2025. https:\/\/virtualheadachespecialist.com\/migraine-and-cluster-headache-neuromodulatory-devices-what-are-the-differences-do-they-really-work-and-which-is-best-for-you\/. Accessed 14 Aug 2025."},{"key":"3500_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/13696998.2023.2205751","volume":"26","author":"R Cowan","year":"2023","unstructured":"Cowan R, Stark-Inbar A, Rabany L, et al. Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention. J Med Econ. 2023;26:656\u201364.","journal-title":"J Med Econ"},{"key":"3500_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1190062","volume":"14","author":"D Song","year":"2023","unstructured":"Song D, Li P, Wang Y, Cao J. Noninvasive vagus nerve stimulation for migraine: a systematic review and meta\u2011analysis of randomized controlled trials. Front Neurol. 2023;14:1190062. https:\/\/doi.org\/10.3389\/fneur.2023.1190062.","journal-title":"Front Neurol"},{"key":"3500_CR28","unstructured":"Oxford Centre for Evidence-Based Medicine (OCEBM). Levels of evidence. 2009. Oxford: Centre for Evidence-Based Medicine; 2009. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed 8 Jan 2025."},{"key":"3500_CR29","unstructured":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 8 Jan 2025."},{"key":"3500_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/0333102419828967","volume":"39","author":"HC Diener","year":"2019","unstructured":"Diener HC, Tassorelli C, Dodick DW, et al. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: fourth edition. Cephalalgia. 2019;39:687\u2013710. https:\/\/doi.org\/10.1177\/0333102419828967.","journal-title":"Cephalalgia"},{"key":"3500_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01826-y","volume":"25","author":"J Versijpt","year":"2024","unstructured":"Versijpt J, Deligianni C, Hussain M, et al. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol. J Headache Pain. 2024;25:119. https:\/\/doi.org\/10.1186\/s10194-024-01826-y.","journal-title":"J Headache Pain"},{"key":"3500_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2982.2004.00819.x","volume":"25","author":"WB Young","year":"2005","unstructured":"Young WB, Rozen TD. Preventive treatment of migraine: effect on weight. Cephalalgia. 2005;25:1\u201311. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00819.x.","journal-title":"Cephalalgia"},{"key":"3500_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15499","volume":"5","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Pozo-Rosich P, Blumenfeld AM, et al. Rates of response to atogepant for migraine prophylaxis among adults: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2022;5:e2215499. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15499.","journal-title":"JAMA Netw Open"},{"key":"3500_CR34","first-page":"404","volume":"33","author":"G Demaagd","year":"2008","unstructured":"Demaagd G. The pharmacological management of migraine, part 1: overview and abortive therapy. PT. 2008;33:404\u201316.","journal-title":"PT"},{"key":"3500_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14060600","volume":"14","author":"LA Pini","year":"2024","unstructured":"Pini LA, Cottafavi K, Ferri P. The nursing role in the management of medication overuse headache: realities and prospects. Brain Sci. 2024;14:600. https:\/\/doi.org\/10.3390\/brainsci14060600.","journal-title":"Brain Sci"},{"issue":"3","key":"3500_CR36","volume":"15","author":"T Turankar","year":"2023","unstructured":"Turankar T, Sorte A, Wanjari MB, Chakole S, Sawale S. Relation and treatment approach of migraine in pregnancy and breastfeeding. Cureus. 2023;15(3):e36828.","journal-title":"Cureus"},{"key":"3500_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01727-0","volume":"25","author":"C Lazaro-Hernandez","year":"2024","unstructured":"Lazaro-Hernandez C, Caronna E, Rosell-Mirmi J, et al. Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population. J Headache Pain. 2024;25:21. https:\/\/doi.org\/10.1186\/s10194-024-01727-0.","journal-title":"J Headache Pain"},{"key":"3500_CR38","first-page":"17","volume":"99","author":"H Ha","year":"2019","unstructured":"Ha H, Gonzalez A. Migraine headache prophylaxis. Am Fam Physician. 2019;99:17\u201324.","journal-title":"Am Fam Physician"},{"key":"3500_CR39","first-page":"72","volume":"73","author":"S Modi","year":"2006","unstructured":"Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006;73:72\u20138.","journal-title":"Am Fam Physician"},{"key":"3500_CR40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/ndt.s3497","volume":"4","author":"D D\u2019Amico","year":"2008","unstructured":"D\u2019Amico D, Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4:1155\u201367. https:\/\/doi.org\/10.2147\/ndt.s3497.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3500_CR41","unstructured":"Goeddertz BK. Patient education for treatment and prophylaxis of migraine. 2008. Grand Forks (ND): University of North Dakota; 2008. https:\/\/commons.und.edu\/theses\/4727. Accessed 8 Jan 2025."},{"key":"3500_CR42","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1503\/cmaj.221607","volume":"195","author":"V Tzankova","year":"2023","unstructured":"Tzankova V, Becker WJ, Chan TLH. Pharmacologic prevention of migraine. CMAJ. 2023;195:E187\u201392. https:\/\/doi.org\/10.1503\/cmaj.221607.","journal-title":"CMAJ"},{"key":"3500_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","volume":"15","author":"T Sprenger","year":"2018","unstructured":"Sprenger T, Viana M, Tassorelli C. Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics. 2018;15:313\u201323. https:\/\/doi.org\/10.1007\/s13311-018-0621-8.","journal-title":"Neurotherapeutics"},{"key":"3500_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/head.12891","volume":"56","author":"J VanderPluym","year":"2016","unstructured":"VanderPluym J, Evans RW, Starling AJ. Long-term use and safety of migraine preventive medications. Headache. 2016;56:1335\u201343. https:\/\/doi.org\/10.1111\/head.12891.","journal-title":"Headache"},{"key":"3500_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.753736.","volume":"2","author":"J Ailani","year":"2022","unstructured":"Ailani J, Rabany L, Tamir S, Ironi A, Starling A. Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine. Front Pain Res. 2022;2:753736. https:\/\/doi.org\/10.3389\/fpain.2021.753736.","journal-title":"Front Pain Res"},{"key":"3500_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40122-020-00185-1","volume":"9","author":"H Nierenburg","year":"2020","unstructured":"Nierenburg H, Vieira JR, Lev N, et al. Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: an open-label pilot study. Pain Ther. 2020;9:531\u201343.","journal-title":"Pain Ther"},{"key":"3500_CR47","unstructured":"Blue Cross Blue Shield of Massachusetts. Remote electrical neuromodulation for migraine. 2023. Boston (MA). 2023. https:\/\/www.bluecrossma.org\/medical-policies\/sites\/g\/files\/csphws2091\/files\/acquiadam-assets\/145%20Remote%20Electrical%20Neuromodulation%20for%20Migraine.pdf. Accessed 8 Jan 2025."},{"key":"3500_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2023.1247313","volume":"4","author":"TS Monteith","year":"2023","unstructured":"Monteith TS, Stark-Inbar A, Shmuely S, et al. Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects. Front Pain Res. 2023;4:1247313. https:\/\/doi.org\/10.3389\/fpain.2023.1247313.","journal-title":"Front Pain Res"},{"key":"3500_CR49","unstructured":"American Headache Society. Migraine, pregnancy, and lactation Mount Royal (NJ). https:\/\/americanheadachesociety.org\/resources\/primary-care\/migraine-pregnancy-and-lactation. Accessed 8 Jan 2025."},{"issue":"4 Headache","key":"3500_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/CON.0000000000000199","volume":"21","author":"SD Silberstein","year":"2015","unstructured":"Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973\u201389. https:\/\/doi.org\/10.1212\/CON.0000000000000199.","journal-title":"Continuum (Minneap Minn)"},{"key":"3500_CR51","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D, Dodick DW, Grosberg BM, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59:1240\u201352. https:\/\/doi.org\/10.1111\/head.13551.","journal-title":"Headache"},{"key":"3500_CR52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54270","author":"S Singh","year":"2024","unstructured":"Singh S, Srinivasan AV, Banerjee TK, et al. Indian consensus on the role of amitriptyline in migraine prophylaxis. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.54270.","journal-title":"Cureus"},{"key":"3500_CR53","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/00325481.2020.1767402","volume":"132","author":"W Cooper","year":"2020","unstructured":"Cooper W, Doty EG, Hochstetler H, Hake A, Martin V. The current state of acute treatment for migraine in adults in the United States. Postgrad Med. 2020;132:581\u20139. https:\/\/doi.org\/10.1080\/00325481.2020.1767402.","journal-title":"Postgrad Med"},{"key":"3500_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2021.102208","volume":"54","author":"AL Aguilar-Shea","year":"2022","unstructured":"Aguilar-Shea AL, Membrilla MJA, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022;54:102208. https:\/\/doi.org\/10.1016\/j.aprim.2021.102208.","journal-title":"Aten Primaria"},{"key":"3500_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/0972-2327.83100","volume":"14","author":"K Ravishankar","year":"2011","unstructured":"Ravishankar K, Chakravarty A, Chowdhury D, Shukla R, Singh S. Guidelines on the diagnosis and the current management of headache and related disorders. Ann Indian Acad Neurol. 2011;14:40. https:\/\/doi.org\/10.4103\/0972-2327.83100.","journal-title":"Ann Indian Acad Neurol"},{"key":"3500_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.18231\/j.ijn.2022.048","volume":"8","author":"N Bangale","year":"2023","unstructured":"Bangale N, Erande S, Sundar KS, et al. Deciphering optimal management options for headache. IP Indian J Neurosci. 2023;8:234\u20137. https:\/\/doi.org\/10.18231\/j.ijn.2022.048.","journal-title":"IP Indian J Neurosci"},{"key":"3500_CR57","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2022.12.0314520220002042022","author":"K Bhave","year":"2022","unstructured":"Bhave K, Tondare S, Pandit P, Patankar R. Drug use pattern and quality of life in patients with migraine at a tertiary care hospital in India: an observational study. Natl J Physiol Pharm Pharmacol. 2022. https:\/\/doi.org\/10.5455\/njppp.2022.12.0314520220002042022.","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"3500_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212785","volume":"14","author":"JL Jackson","year":"2019","unstructured":"Jackson JL, Kuriyama A, Kuwatsuka Y, et al. Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. PLoS ONE. 2019;14:e0212785. https:\/\/doi.org\/10.1371\/journal.pone.0212785.","journal-title":"PLoS ONE"},{"key":"3500_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14090938","volume":"14","author":"A Radoji\u010di\u0107","year":"2024","unstructured":"Radoji\u010di\u0107 A, Mili\u0107evi\u0107 A, \u017ddraljevi\u0107 M, et al. Prevalence and awareness of medication overuse headache among undergraduate students at the university of Belgrade. Brain Sci. 2024;14:938. https:\/\/doi.org\/10.3390\/brainsci14090938.","journal-title":"Brain Sci"},{"key":"3500_CR60","doi-asserted-by":"publisher","DOI":"10.1177\/03331024251321500","volume":"45","author":"R Ornello","year":"2025","unstructured":"Ornello R, Caponnetto V, Ahmed F, et al. Evidence-based guidelines for the pharmacological treatment of migraine, summary version. Cephalalgia. 2025;45:3331024251321500. https:\/\/doi.org\/10.1177\/03331024251321500.","journal-title":"Cephalalgia"},{"key":"3500_CR61","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/JPR.S203650","volume":"13","author":"R Shafqat","year":"2020","unstructured":"Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ. Updated evaluation of IV dihydroergotamine (DHE) for refractory migraine: patient selection and special considerations. J Pain Res. 2020;13:859\u201364. https:\/\/doi.org\/10.2147\/JPR.S203650.","journal-title":"J Pain Res"},{"key":"3500_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02035-x","volume":"26","author":"S Pavitt","year":"2025","unstructured":"Pavitt S, Morris C, Shin L, et al. Tolerability of repetitive dihydroergotamine infusions paired with an adjustment in preventive treatment strategy in chronic headache disorders in children and youth. J Headache Pain. 2025;26:93. https:\/\/doi.org\/10.1186\/s10194-025-02035-x.","journal-title":"J Headache Pain"},{"key":"3500_CR63","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/head.14636","volume":"63","author":"VS Wang","year":"2023","unstructured":"Wang VS, Kosman J, Yuan H, et al. Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: a retrospective study. Headache. 2023;63:1251\u20138. https:\/\/doi.org\/10.1111\/head.14636.","journal-title":"Headache"},{"key":"3500_CR64","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s42399-021-00868-6","volume":"3","author":"AG Voloshin","year":"2021","unstructured":"Voloshin AG, Moiseeva IV. Combined interventional treatment of refractory chronic migraine. SN Comprehen Clin Med. 2021;3:1320\u20136. https:\/\/doi.org\/10.1007\/s42399-021-00868-6.","journal-title":"SN Comprehen Clin Med"},{"key":"3500_CR65","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D, Volokh L, Ironi A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88:1250\u20135. https:\/\/doi.org\/10.1212\/WNL.0000000000003760.","journal-title":"Neurology"},{"key":"3500_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02021-3","volume":"26","author":"H BaniHani","year":"2025","unstructured":"BaniHani H, Lampl C, MaassenvandenBrink A, et al. The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical Federation. J Headache Pain. 2025;26:100. https:\/\/doi.org\/10.1186\/s10194-025-02021-3.","journal-title":"J Headache Pain"},{"key":"3500_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000966","volume":"6","author":"B Grosberg","year":"2021","unstructured":"Grosberg B, Rabany L, Lin T, et al. Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study. Pain Rep. 2021;6:e966. https:\/\/doi.org\/10.1097\/PR9.0000000000000966.","journal-title":"Pain Rep"},{"key":"3500_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00226","volume":"11","author":"MJ Marmura","year":"2020","unstructured":"Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11:226. https:\/\/doi.org\/10.3389\/fneur.2020.00226.","journal-title":"Front Neurol"},{"key":"3500_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2025.1525464","volume":"6","author":"F Alnajjar","year":"2025","unstructured":"Alnajjar F, Kalantari A, Shalaby A, Teo J, Al-Jumeily D, Hussain A. A comprehensive review of remote electrical neuromodulation (REN): efficacy, safety, and future perspectives. Front Pain Res (Lausanne). 2025;6:1525464. https:\/\/doi.org\/10.3389\/fpain.2025.1525464.","journal-title":"Front Pain Res (Lausanne)"},{"key":"3500_CR70","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/head.14042","volume":"61","author":"AD Hershey","year":"2021","unstructured":"Hershey AD, Lin T, Gruper Y, et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache. 2021;61:310\u20137. https:\/\/doi.org\/10.1111\/head.14042.","journal-title":"Headache"},{"key":"3500_CR71","unstructured":"American Headache Society. Update on noninvasive neuromodulation devices for headache treatment: consensus statement. Pract Neurol. 2023. https:\/\/practicalneurology.com\/diseases-diagnoses\/headache-pain\/update-on-noninvasive-neuromodulation-devices-for-headache-treatment\/32129\/. Accessed 14 Aug 2025."},{"key":"3500_CR72","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40120-023-00576-4","volume":"13","author":"T Alsaadi","year":"2024","unstructured":"Alsaadi T, Kayed DM, Al-Madani A, et al. Acute treatment of migraine: expert consensus statements from the United Arab Emirates (UAE). Neurol Ther. 2024;13:257\u201381. https:\/\/doi.org\/10.1007\/s40120-023-00576-4.","journal-title":"Neurol Ther"},{"key":"3500_CR73","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/pm\/pnac021","volume":"23","author":"DC Buse","year":"2022","unstructured":"Buse DC, Rabany L, Lin T, Ironi A, Connelly MA, Bickel JL. Combining guided intervention of education and relaxation (GIER) with remote electrical neuromodulation (REN) in the acute treatment of migraine. Pain Med. 2022;23:1544\u20139. https:\/\/doi.org\/10.1093\/pm\/pnac021.","journal-title":"Pain Med"},{"key":"3500_CR74","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/head.14586","volume":"63","author":"A Peretz","year":"2024","unstructured":"Peretz A, Stark-Inbar A, Harris D, et al. Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey-study. Headache. 2023; 63:968\u201370. https:\/\/doi.org\/10.1111\/head.14586","journal-title":"Headache"},{"key":"3500_CR75","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12325-023-02697-6","volume":"41","author":"A Synowiec","year":"2024","unstructured":"Synowiec A, Stark-Inbar A, Weinstein M, Ironi A, Mauskop A. One-year consistent safety, utilization, and efficacy assessment of remote electrical neuromodulation (REN) for migraine treatment. Adv Ther. 2024;41:170\u201381. https:\/\/doi.org\/10.1007\/s12325-023-02697-6.","journal-title":"Adv Ther"},{"key":"3500_CR76","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s40122-021-00276-7","volume":"10","author":"H Nierenburg","year":"2021","unstructured":"Nierenburg H, Rabany L, Lin T, et al. Remote electrical neuromodulation (REN) for the acute treatment of menstrual migraine: a retrospective survey study of effectiveness and tolerability. Pain Ther. 2021;10:1245\u201353. https:\/\/doi.org\/10.1007\/s40122-021-00276-7.","journal-title":"Pain Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03500-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:14:16Z","timestamp":1775726056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03500-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3500"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03500-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nerivio\n                      \u00ae\n                      is distributed by Dr.\u00a0Reddy\u2019s Laboratories in India. The expert committee, including Debashish Chowdhury, Jaydip Ray Chaudhuri, Pravar Passi, Rajasekar Reddi, Rajiv Anand, Sumit Singh, T K Banerjee, and Vikram Sharma, members of the scientific advisory board of Dr.\u00a0Reddy\u2019s Laboratories, declares that they have no competing interests. Mayank Ravindra Dhore, Sujeet Narayan Charugulla, Bhavesh P Kotak, and Sukhpreet Singh are employees of Dr.\u00a0Reddy\u2019s Laboratories.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical clearance for the study was obtained from the Aditya College of Engineering and Advanced Studies (ACEAS) Independent Ethics Committee, Gujarat, India, approval number EC\/BQ\/P-1\/3\/3\/25, dated 03 March 2025. The study was conducted in accordance with the Declaration of Helsinki (1964) and its later amendments. All participating experts provided written informed consent before their involvement in the consensus meetings. Confidentiality of participant responses was maintained throughout the study, and any potential conflicts of interest were fully disclosed. Digital informed consent was obtained from all the experts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}